Lyell Immunopharma, Inc. (LYEL)

23.50 -1.05 (-4.28%) USD  |  NASDAQ  |  Jan 12, 10:58
More

Lyell Immunopharma Operating Income (TTM)

Operating Income (TTM) Chart

View Operating Income (TTM) for LYEL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Operating Income (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Operating Income (TTM) Range, Past 5 Years

View Operating Income (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Operating Income (TTM) Benchmarks

View Operating Income (TTM) Benchmarks
Start Trial
Insmed, Inc. Upgrade
Nektar Therapeutics Upgrade
GT Biopharma, Inc. Upgrade
Ionis Pharmaceuticals, Inc. Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade